On May 17, 2026, the Director-General of the World Health Organization declared the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo and Uganda a Public Health Emergency of International Concern, the second-highest alarm in its rulebook, one rung below a pandemic emergency. Then he convened the Emergency Committee — the expert body whose advice the International Health Regulations tell him to weigh when he makes that call, and which, until that weekend, had always been heard first.
He did it backwards, for the first time in WHO history. Two days later the committee met, reviewed the evidence, and agreed that the outbreak met the bar for a global emergency. Temporary recommendations followed on May 22.
From the outside, the whole sequence looks like a procedural shortcut that didn’t matter, since the experts agreed anyway. Yet that agreement suggests where the delay usually comes from. The bottleneck was not expertise or data, or a genuine disagreement about whether a rarely seen Ebola virus spreading internationally with no approved vaccine or treatment constituted a global emergency. The bottleneck was the architecture: a committee-convening, consensus-seeking, closed-door deliberation process that, by its own procedural logic, takes days an outbreak doesn’t have.
Tedros Adhanom Ghebreyesus was right to bypass his own committee. What needs explaining is a system in which the fastest route to the outcome he needed was a rarely used clause, Article 12(2), which lets the Director-General declare once the affected states agree and seek the committee’s views afterward, and which then validated that shortcut without changing its usual procedure. That system rests on the International Health Regulations, a treaty drafted in a different era to solve a different problem than the one that keeps killing people.
The machine
A PHEIC sounds, to anyone hearing the term for the first time, like the international equivalent of pulling a fire alarm: the world’s loudest health alarm short of a declared pandemic. It is easy to assume it compels a response, with funding flowing, borders coordinated and governments acting.
The system was never built to compel any of that. The International Health Regulations, adopted in 2005, are a binding treaty on 196 States Parties.
Their obligations run in several directions, but not the direction that matters when people are dying. States must notify the WHO within 24 hours of assessing events that may constitute a PHEIC. They must also develop and maintain core public health surveillance and response capacities, though compliance has been thin from the start, and deadline extensions have been granted so routinely that the requirement is aspirational in practice. Article 44 asks states to collaborate with each other in detection, response, technical cooperation, and mobilizing financial resources, but only “to the extent possible,” a limit each state judges for itself.
When the Director-General declares a PHEIC under Article 12, the temporary recommendations issued under Article 15 are, in the treaty’s own definition, “non-binding advice,” and that is what a global health emergency delivers to sovereign states.
What the IHR does bind, and binds tightly, is the opposite failure: doing too much. Article 43 requires any state whose extra measures significantly interfere with international traffic, such as refusing or delaying travellers or cargo for more than 24 hours, to base them on scientific evidence and, unless WHO recommended them, report them and their rationale within 48 hours.
The entire legal architecture was constructed to prevent overreaction: governments shutting borders, cutting trade routes, punishing affected countries economically out of panic or political theatre. The IHR constrains what states habitually do too much of, which is restricting trade, and asks only loosely, with no enforcement, for what they consistently do too little of, which is funding and mounting a response in the affected country.
The asymmetry was deliberate. The IHR was negotiated in the early 2000s, in the aftermath of SARS, when the governing fear among member states was economic damage from excessive quarantine measures. China’s economy had been battered by travel advisories, and Toronto’s tourism sector had cratered. The political energy behind the IHR revision went into preventing that kind of overreaction, not into compelling underfunded, under-resourced countries to mount emergency responses they couldn’t afford.
The amendments adopted in June 2024 didn’t fix this. They introduced a “Coordinating Financial Mechanism” built entirely on voluntary contributions, with no binding funding commitments from wealthy states. Eleven States Parties rejected even these modest changes before they took effect: the United States, Germany, Canada, Brazil, Italy, Argentina, Austria, the Czech Republic, Israel, the Netherlands and the Philippines. Seven of them cited unfinished domestic procedures rather than outright opposition. For most other states, the amendments entered into force in September 2025. The list has kept moving since: Germany withdrew its rejection in February 2026, while Iran, New Zealand and Slovakia lodged rejections of their own in March 2026. But the fundamental architecture remained intact: the WHO can still declare emergencies it has no power to resolve.
The disconnect between the international and the domestic runs deep. Clare Wenham and Liam Stout mapped the emergency legislation of 48 WHO member states, less than a quarter of the total and not a representative sample. Only 16% had any reference to “PHEIC” in their domestic law, and fewer than 40% even used the term “pandemic.” In most of the countries examined, the WHO’s flagship alert designation doesn’t exist in law.
If that sample is any guide, the system can sound an alarm that much of its audience has no domestic legal obligation to hear, and it has no means to compel a response from any of them.
Every PHEIC since 2005
Nine PHEICs have been declared under the IHR, and compliance with their temporary recommendations has been consistently poor. H1N1, 2009: about a quarter of governments restricted pork imports, directly contradicting WHO guidance that the virus was not transmitted through food. Polio, 2014 and ongoing: still in force more than twelve years later, with wild poliovirus entrenched in Pakistan and Afghanistan. Ebola in West Africa, 2014: roughly a quarter of states imposed travel restrictions against WHO advice. Zika, 2016: WHO advised against any travel or trade restrictions, leaving governments little to defy. Ebola in Kivu, 2019: trade and travel measures imposed beyond recommendations. COVID-19, 2020: WHO explicitly recommended against travel restrictions on January 30; by the end of March, effectively all 196 States Parties had imposed border controls, and as early as February 7 two-thirds of the countries restricting travel had not reported their measures as required under Article 43. Mpox, 2022: the Emergency Committee split 9-6 against declaring; Tedros declared anyway, calling himself the “tiebreaker.” Mpox clade I, 2024: the second declaration for the same disease in two years, with vaccine access for African nations months behind wealthy countries. Bundibugyo Ebola, 2026: declared before the committee even convened.Bundibugyo
What the PHEIC system’s architecture means in practice depends on the specific emergency. The 2026 Bundibugyo outbreak happens to expose every limitation at once: no medical countermeasure, active armed conflict, confirmed international spread, and a funding vacuum that no IHR mechanism can fill.
Bundibugyo ebolavirus is one of six known species in the genus. The two Ebola vaccines that made it to market, Merck’s Ervebo and Johnson & Johnson’s two-dose Zabdeno/Mvabea, were built against the Zaire species, and neither is licensed for Bundibugyo. Janssen gave up the EU authorization for Zabdeno/Mvabea for commercial reasons in May 2026. WHO’s experts judge the evidence that Ervebo cross-protects to be limited and inconclusive, and want it used only inside research studies. The FDA-approved antibody treatments, Ebanga and Inmazeb, proved themselves against the Zaire species in the 2018–2019 PALM trial in the DRC. Against Bundibugyo, the arsenal of the past decade offers leads, not cures: WHO has prioritized one Inmazeb component (maftivimab), the experimental antibody cocktail MBP134 and the antiviral remdesivir for testing in clinical trials, and none of them is proven.
CEPI is fast-tracking three investigational vaccine candidates: rVSV-BDBV-GP from IAVI, ChAdOx1-BDBV from the University of Oxford and the Serum Institute of India, and an mRNA candidate from Moderna. A WHO expert consultation on May 28 assessed the Oxford candidate as potentially ready for clinical trial assessment within two to three months, contingent on additional animal data. The IAVI candidate requires an estimated seven to nine months before it’s ready for a clinical trial. Moderna’s timeline was not yet specified. Even the fastest of these paths leads to a clinical trial, not a deployable vaccine. A trial still has to prove protection and clear regulatory review, even with CEPI paying for doses to be manufactured in parallel, and the vaccine must then be distributed into a conflict zone where supply chains are routinely looted or destroyed. In late May, the gap between where the science stood and a health worker in Ituri Province holding a proven Bundibugyo vaccine was likely to be measured in years rather than months.
The outbreak is expanding into terrain where classical public health containment is functionally impossible. On June 3, WHO reported 344 confirmed cases, including 60 deaths, in the DRC, spread across Ituri, North Kivu and South Kivu provinces, with treatment units already open as far south as Goma and Bukavu.
Fifteen confirmed cases had been identified in Uganda, including in Kampala, a city of several million with direct international air connections to Nairobi, Dubai, Addis Ababa, and beyond. In the DRC, contact tracing was reaching roughly 45% of identified contacts; getting ahead of an Ebola outbreak takes more than 90%.
The available tools are early isolation, contact tracing, infection prevention, and safe burials, all of which require community trust and physical access to work. In much of eastern DRC there is too little of the first, and armed conflict makes the second unsafe.
Ituri Province is contested by the ADF, an ISIS-affiliated armed group responsible for some of the region’s deadliest attacks on civilians, and by ethnic militias, while the Rwanda-backed M23 has held Goma and Bukavu, and large parts of North and South Kivu, since early 2025. Health facilities are either destroyed or operating under threat.
Community engagement teams, who knock on doors, trace contacts and explain why safe burial matters, cannot operate safely in areas under active armed-group control. Nearly ten million people across Ituri, North Kivu, South Kivu and neighboring Tanganyika face acute hunger, which means populations are mobile, malnourished, harder to find, and largely beyond the reach of health systems or messaging.
“We cannot build community trust or isolate the sick while bombs are falling,” Tedros wrote on May 27 — days before he traveled to Ituri to see the epicenter for himself.
The PHEIC, meanwhile, generated temporary recommendations: non-binding advice addressed to 196 sovereign states. What the outbreak requires is a vaccine that doesn’t exist, a ceasefire that no health authority can impose, and a funded response plan that no mechanism in the International Health Regulations can compel anyone to pay for. Better management would not close the distance between what the declaration produces and what the emergency demands, because the limitation is built into the instrument.
The Bundibugyo virus
First identified in 2007 in Bundibugyo District, Uganda, Bundibugyo ebolavirus had caused only small, geographically isolated outbreaks before 2026, which is why no vaccine existed for it. Historical case fatality rates are lower than Zaire’s 50–90%: about a third of confirmed patients died in both earlier outbreaks, in Uganda in 2007 and in Congo in 2012, though WHO puts the 2012 toll near 50% once probable cases are counted. But the virus has been poorly studied because outbreaks never lasted long enough or spread far enough to attract sustained research investment. The species-specificity problem in ebolavirus vaccine development is fundamental: protection against one of the six known species cannot be assumed against another, and the evidence that the Zaire vaccine shields against Bundibugyo is limited and inconclusive. The three candidates CEPI is betting on come from IAVI, from Oxford and the Serum Institute of India, and from Moderna.The last time
In earlier emergencies the delay ran the other way: the organization itself held the alarm back, for months.
The 2014 West Africa Ebola epidemic followed a structure that should by now be recognizable. The first cases appeared in Guinea in December 2013, and WHO was notified in March 2014. By June, Médecins Sans Frontières had publicly declared the outbreak “out of control,” a judgment the WHO did not share, at least not publicly.
The WHO didn’t declare a PHEIC until August 8, 2014, 138 days after notification, by which point more than 1,700 cases had been reported and over 960 people had died.
The delay was a calculation, and it reveals how deeply the IHR’s design asymmetry had been internalized by the institution supposedly operating above it. WHO leadership feared that a PHEIC declaration would trigger the very overreaction the IHR was built to prevent: trade and travel restrictions that would devastate three of the world’s poorest countries. WHO officials weighed a probable Saudi restriction on West African Muslims attending the Hajj, which would have had severe economic and political consequences for Guinea, Liberia, and Sierra Leone. Airlines were already reducing flights. Foreign investors were pulling out. A formal PHEIC, WHO’s leadership calculated, would accelerate the economic collapse it was supposed to help prevent.
Dr. Sylvie Briand, then heading WHO’s Pandemic and Epidemic Diseases Department, wrote internally in June 2014 that she did not think declaring a PHEIC would “help fight the epidemic at this stage,” because “one has to make recommendations and these risk hurting the country without helping public health.” She described invoking the IHR as “a last resort.”
The catastrophic economic consequences arrived regardless. The World Bank put the three countries’ lost output at about US$2.2 billion through 2015. Fear drove most of it, in the form of the “aversion behavior” that emptied markets, mines and flights; the travel restrictions other states imposed in spite of WHO advice deepened the damage. Roughly a quarter of the world’s governments restricted travel from the affected countries. The system designed to prevent economic punishment could not prevent it.
And by delaying the declaration to minimize that risk, WHO allowed the outbreak to reach a scale that multiplied every cost. It ended with about 28,600 cases and 11,300 deaths.
Reviews of what had gone wrong followed. The Harvard-LSHTM Independent Panel, reporting in November 2015, proposed ten structural reforms. Among them were a transparent, politically protected standing Emergency Committee empowered to declare emergencies by majority vote, replacing the ad hoc system; an independent Accountability Commission for system-wide assessment; and a framework of norms and rules for sharing research data and its benefits.
The Ebola Interim Assessment Panel, reporting in July 2015, urged what became a recurring fix in the post-2014 reviews: an intermediate alert level below PHEIC, enabling graduated early engagement before a crisis reached full emergency threshold. The IHR Review Committee on Ebola then recommended it outright: the system needed a way to raise the alarm before it reached maximum volume.
Most of these proposals died between recommendation and implementation. They were not forgotten: the WHO cites them in annual reports and reform documents as evidence of institutional learning. They died because implementing them required the consent of the same member states whose behavior they were designed to constrain.
The WHO Health Emergencies Programme was created in July 2016, a real structural addition and the reform most often cited as proof the system responded to 2014. But it was set up as an all-hazards programme for outbreaks and humanitarian crises, and in 2020 its own Independent Oversight and Advisory Committee warned that investment in preparedness had been insufficient and found most countries ill-prepared for a pandemic of COVID-19’s scale. The Contingency Fund for Emergencies was built around a US$100 million target first proposed by the IHR Review Committee that examined the H1N1 response. In 2025 the fund received $10.6 million in contributions and released almost $30 million, nearly three times what it took in.
Then there was the Pandemic Emergency Financing Facility, the World Bank’s flagship attempt to securitize pandemic risk, whose pandemic bonds were sold in 2017 with considerable fanfare. The facility raised $425 million through pandemic bonds and insurance swaps and paid investors approximately $100 million in coupons over the life of the instruments. Its trigger criteria were so restrictive that by the time COVID-19 qualified for a payout, the pandemic was already killing thousands daily across multiple continents. The payout of about US$196 million was triggered in mid-April 2020, allocated to 64 countries ten days later and not fully transferred until the end of September. It arrived months into the pandemic, and investors had already pocketed roughly half that sum in interest. Lawrence Summers, the former World Bank chief economist, called the whole venture “an embarrassing mistake” and a symptom of “financial goofiness.” The World Bank did not renew the bonds when they matured in July 2020.
So the new programme was understaffed, the emergency kitty chronically underfunded, and the financial instrument paid investors handsomely and paid out too late to matter.
And the intermediate alert level, a reform that review after review put forward to prevent delayed responses, was debated for the better part of a decade and never adopted. The 2024 IHR amendments instead introduced a “pandemic emergency” tier above PHEIC, adding escalation capacity when the diagnosed problem was the system’s inability to raise the alarm earlier.
As of June 2026, there is still no formal alert short of a PHEIC. WHO’s internal emergency grades let it send staff and money before any declaration, but the treaty offers no way to sound the international alarm at anything less than maximum volume. The system learned the right lessons after 2014 and identified the correct structural fixes, but it could not implement them.
The pattern beneath the pattern
It would be comforting to treat 2014 as uniquely bad: the wrong leader at the wrong moment, a system caught flat-footed for the first time. But the same dynamics have reproduced with different variables and an identical outcome, which points to a structural explanation.
The 2018–2020 DRC Ebola outbreak in Kivu was declared in August 2018 and would eventually kill over 2,200 people, the second-deadliest Ebola outbreak in history at the time. The Emergency Committee convened and declined to recommend a PHEIC three consecutive times between October 2018 and June 2019. The reasoning shifted from meeting to meeting, but kept circling back to the same conclusion: a declaration would add little to the response and could cost the DRC dearly. By the third refusal, the virus had already crossed into Uganda, killing a five-year-old boy and his grandmother in Kasese district. The committee still said no, on the stated grounds that the risk of spread beyond the region remained low, even while rating the national and regional risk very high, and that a PHEIC could damage the DRC’s economy. It was the same logic, almost verbatim, that had delayed the 2014 declaration by 138 days.
The PHEIC was declared on July 17, 2019, nearly a full year into the outbreak, and only after a case appeared in Goma, a city of two million with an international airport, sitting on the Rwandan border.
Goma triggered what the epidemiological evidence could not: political salience. With a different Director-General and in a different geography, the same architecture had produced the same delay.
The compliance record is no better. During COVID-19, WHO explicitly recommended against travel restrictions on January 30, 2020, and by the end of March effectively every state party had imposed them.
The mpox declarations confirmed the pattern in yet another register. In July 2022 the Emergency Committee voted 9 to 6 against a PHEIC; Tedros declared one anyway, calling himself the “tiebreaker” and stretching the procedural norms further than they had ever been stretched. As for the declaration itself, the WHO’s recommendation of equitable access became, as usual, non-binding advice that nobody was bound by. In August 2024 came a second mpox PHEIC, for clade I spread across Africa: a more dangerous variant, concentrated in the DRC and neighbouring countries, with vaccine access for African nations months behind wealthy ones. The same continent bore the burden again while the system processed its own procedures.
The sharpest finding goes to the mechanism itself. Catherine Worsnop and colleagues analyzed the COVID-19 response and found that WHO’s emergency declaration and pandemic announcement, both of which advised against border restrictions, were associated with an increase in the number of states imposing them. One explanation fits the pattern: when the WHO declares the highest possible alert and simultaneously advises governments not to close borders, governments hear the alert and ignore the advice. The declaration works as a severity signal, and governments respond to the severity rather than to the recommendation stapled to it.
Nationalist governments, Worsnop found in a follow-up study, were especially likely to impose restrictions and to do so faster, drawn to policies that associate disease with foreigners.
If that explanation holds, the PHEIC mechanism amplifies the overreaction it was designed to constrain, and the treaty has no way to respond except with more non-binding advice.
Inside the Emergency Committee
Emergency Committees are not standing bodies. Each is convened ad hoc by the Director-General from the IHR Expert Roster, deliberates behind closed doors, and seeks consensus. WHO describes the process as a politically neutral, technocratic exercise. Barbara Frossard Pagotto and Mark Eccleston-Turner, drawing on the accounts of people involved in PHEIC decisions, describe a highly politicized one, in which decisions are driven by factors beyond the IHR criteria and shaped by each committee’s composition, the pressures bearing on its members, and the negotiating dynamics of the room.The architecture of impotence
Tedros bypassed the committee in 2026 and the outbreak kept burning, so a faster declaration was not enough. After 2014 the system correctly diagnosed its own failure modes and designed the right reforms, and those reforms were costed, debated and mostly shelved.
The pattern has persisted across Directors-General, pathogens and decades, which points away from any one leader and toward the source of the WHO’s authority.
That authority is, as political scientist Colin McInnes has argued, “on loan” from member states. The entities the IHR is trying to govern are the same entities that govern the IHR. This circularity generates three interlocking dysfunctions that no individual reform can reach, because they are properties of the structure itself.
The first is the consent-authority paradox. After SARS in 2003, Director-General Gro Harlem Brundtland acted assertively, publicly criticizing China for concealing the outbreak and issuing the most stringent travel advisory in WHO’s 55-year history without waiting for member-state consent. It worked, and SARS was contained. But the reward for that success was political backlash: member states accused the WHO of exceeding its mandate, of acting without authorization. The institution absorbed the lesson that acting decisively meant jeopardizing the cooperation of the states whose consent underwrites the organization’s authority. After H1N1 in 2009, proposals for a more operational WHO crisis role were rejected by the same governments that would, five years later, blame the organization for passivity during Ebola.
The cycle is mechanical: states refuse the authority that would enable effective response, then condemn the institution for lacking it. And the condemnation itself becomes the justification for withholding further authority.
The second dysfunction is the enforcement vacuum. States violate IHR obligations without consequence, and they know it. When, in the first weeks of COVID-19, two-thirds of the countries restricting travel failed to report their measures as required under Article 43, nothing happened: there was no investigation, no sanction and no public accounting. Compliance monitoring rests on the State Party Self-Assessment Annual Report, known as SPAR, a self-graded questionnaire in which countries rate their own preparedness, backed by voluntary external evaluations that carry no sanction. The WHO has no inspectorate, no sanctioning power, no enforcement arm of any kind. The 2024 amendments addressed this gap by creating a States Parties Committee whose mandate is explicitly “facilitative and consultative in nature only” and “non-adversarial, non-punitive,” language that rules out the adversarial and punitive functions that would make compliance enforceable.
The third dysfunction is the most corrosive, because it is a perverse incentive wired into the system’s core logic. States that report outbreaks honestly and transparently get punished by other states, which impose the very trade and travel restrictions the IHR was supposed to prevent. Guinea, Liberia, and Sierra Leone lost an estimated US$2.2 billion in output during the 2014–2015 epidemic, and the travel bans and flight suspensions other countries imposed deepened the damage. This creates a rational incentive to delay, minimize, or conceal, because transparency invites economic punishment the treaty cannot stop.
And the WHO itself internalized this incentive in 2014, when it delayed the Ebola PHEIC partly to shield affected countries from the consequences of being declared a global emergency.
The IHR has procedural teeth in one direction only. It demands justification from states that overreact and only unenforced undertakings from states that don’t act at all. Nothing in it compels a wealthy country to fund a response in a poor one, penalizes inaction, or converts a declaration into resources, personnel, or medical countermeasures.
Correcting this asymmetry would require member states to grant the WHO real enforcement authority: the power to compel funding, mandate resource deployment and penalize noncompliance with response obligations the way Article 43 at least nominally constrains trade restrictions. That authority would need to come from the same states whose behavior it would constrain. And the consent-based governance model cannot generate the consent to override itself. The actors who would need to change the system are the actors who benefit, or believe they benefit, from its current design.
Wealthy states that might be compelled to fund responses in poor countries have no interest in creating that compulsion. Poor countries that might gain from it lack the political leverage to demand it.
The Bundibugyo outbreak is not waiting for the architecture to sort out its contradictions. As of early June, confirmed cases were climbing in a conflict zone with no approved vaccine, no specific treatment, and contact tracing reaching fewer than half of identified contacts. The fastest investigational vaccine candidate was months from a clinical trial, let alone deployment. The PHEIC’s temporary recommendations expire in three months unless renewed. And no mechanism in the International Health Regulations converts those recommendations into anything the situation demands: funded response, medical countermeasures, operational access in a war zone. The declaration produced what the treaty’s architects, two decades ago, decided was sufficient, which falls far short of what the outbreak needs.
Update, October 2026: The emergency has not lapsed. The Emergency Committee met again on August 18 and kept the PHEIC in place, and by September 27 the DRC had reported 8,116 confirmed cases and 3,924 confirmed deaths, making this the second-largest Ebola epidemic on record. Uganda’s outbreak, 20 confirmed cases and two deaths, was declared over on August 27. Vaccines moved faster than the June forecast above: under a research protocol, about 2,000 health and frontline workers had received Ervebo by early September, including in Ituri, and by October the Moderna and Oxford/Serum Institute Bundibugyo candidates were both in Phase 1 trials, with CEPI preparing Tumaini, a Phase 2/3 trial to test them alongside Ervebo. There is still no approved vaccine against Bundibugyo.
Five months after the Director-General declared it, the emergency was still in force. The Emergency Committee had met twice and kept the PHEIC in place, while confirmed cases in the DRC grew more than twentyfold and the first vaccine doses reached health workers only under a research protocol.
Every recommendation attached to the emergency still takes the form the treaty gave those of May 22: non-binding advice, addressed to sovereign states whose consent is the only source of the authority being exercised upon them.
Gen AI Disclaimer
Some contents of this page were generated and/or edited with the help of a Generative AI.
Media
World Health Organisation headquarters, Geneva, north and west sides. – Wikipedia
Key Sources and References
WHO, “Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a public health emergency of international concern,” May 17, 2026. https://www.who.int/news/item/17-05-2026-epidemic-of-ebola-disease-in-the-democratic-republic-of-the-congo-and-uganda-determined-a-public-health-emergency-of-international-concern
“WHO declares Ebola outbreak in DRC and Uganda a global health emergency,” STAT, May 17, 2026. https://www.statnews.com/2026/05/17/who-ebola-drc-uganda-bundibugyo-pheic-public-health-emergency/
WHO, “First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic Republic of the Congo and Uganda 2026 — Temporary recommendations,” May 22, 2026. https://www.who.int/news/item/22-05-2026-first-meeting-of-the-ihr-emergency-committee-regarding-the-epidemic-of-ebola-bundibugyo-virus-disease-in-the-democratic-republic-of-the-congo-and-uganda-2026-temporary-recommendations
WHO, International Health Regulations (2005), Third Edition, 2016. https://www.who.int/publications/i/item/9789241580496
WHO, “Amended International Health Regulations enter into force,” September 19, 2025. https://www.who.int/news/item/19-09-2025-amended-international-health-regulations-enter-into-force
WHO, “Amendments to the International Health Regulations (2005),” Seventy-seventh World Health Assembly, A77/A/CONF./14, 2024. https://apps.who.int/gb/ebwha/pdf_files/WHA77/A77_ACONF14-en.pdf
WHO, Circular Letter C.L.18.2026, “Amendments to the International Health Regulations (2005),” May 1, 2026 (copy held in the Estonian public document register). https://adr-docs.karlerss.com/eXHjLUvPojfHCeuv1hVbS0PiHBgFKj18/C.L.18.2026%20IHR%20amendments%20(English).pdf
Gian Luca Burci, “The Entry into Force of the Amendments to WHO’s International Health Regulations,” EJIL: Talk!, October 2025. https://www.ejiltalk.org/the-entry-into-force-of-the-amendments-to-whos-international-health-regulations/
Clare Wenham and Liam Stout, “A legal mapping of 48 WHO member states’ inclusion of public health emergency of international concern, pandemic, and health emergency terminology within national emergency legislation in responding to health emergencies,” The Lancet, Vol. 403, No. 10435, 2024, pp. 1504–1512. https://doi.org/10.1016/S0140-6736(24)00156-9 · https://www.sciencedirect.com/science/article/pii/S0140673624001569 · https://researchonline.lse.ac.uk/id/eprint/121602/
WHO, “Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus,” May 28, 2026. https://www.who.int/news/item/28-05-2026-experts-convened-by-who-advise-on-candidate-treatments-and-vaccines-for-ebola-disease-caused-by-bundibugyo-virus
CEPI, “CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates,” 2026. https://cepi.net/cepi-fast-tracks-three-bundibugyo-ebolavirus-vaccine-candidates
CEPI, “Final preparations underway for pivotal Phase 2/3 Bundibugyo vaccine trial,” October 2026. https://cepi.net/final-preparations-underway-pivotal-phase-23-bundibugyo-vaccine-trial
European Medicines Agency, “Zabdeno: Withdrawn” (marketing authorisation withdrawn May 1, 2026; Mvabea likewise). https://www.ema.europa.eu/en/medicines/human/EPAR/zabdeno
Joseph F. Wamala et al., “Ebola Hemorrhagic Fever Associated with Novel Virus Strain, Uganda, 2007–2008,” Emerging Infectious Diseases, Vol. 16, No. 7, 2010. https://doi.org/10.3201/eid1607.091525
European Society for Clinical Virology, “Case of the month: Molecular analysis of the 2012 Bundibugyo virus disease outbreak in Uganda and Congo.” https://escv.eu/case-of-the-month-molecular-analysis-of-the-2012-bundibugyo-virus-disease-outbreak-in-uganda-and-congo/
U.S. Food and Drug Administration, “FDA approves treatment for Ebola virus,” December 2020. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-treatment-ebola-virus
Council on Foreign Relations, “Violence in the Democratic Republic of Congo,” Global Conflict Tracker. https://www.cfr.org/global-conflict-tracker/conflict/violence-democratic-republic-congo
Integrated Food Security Phase Classification, “Democratic Republic of the Congo: Acute Food Insecurity Projection Update, January–June 2026.” https://www.foodsecurityportal.org/sites/default/files/2026-05/IPC_DRC_Acute_Food_Insecurity_Projection_Update_Jan_Jun2026_Snapshot_English.pdf
WHO Director-General, message posted on X (formerly Twitter), May 27, 2026, reported by Al Jazeera, “DRC facing ‘catastrophic collision’ of Ebola and war, WHO chief warns,” May 27, 2026. https://www.aljazeera.com/news/2026/5/27/drc-facing-catastrophic-collision-of-ebola-and-war-who-chief-warns
WHO, “Director-General’s opening remarks at the media briefing on the Bundibugyo Ebola outbreak,” June 3, 2026. https://www.who.int/news-room/speeches/item/who-director-general-s-opening-remarks-at-the-media-briefing—3-june-2026
WHO Disease Outbreak News, “Ebola disease caused by Bundibugyo virus — Democratic Republic of the Congo and Uganda,” 2026-DON605. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON605
WHO Disease Outbreak News, “Ebola disease caused by Bundibugyo virus — Democratic Republic of the Congo,” 2026-DON617, September 10, 2026. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON617
UK Health Security Agency, “Outbreaks under monitoring in 2026: week 39 (week ending 27 September 2026),” GOV.UK. https://www.gov.uk/government/publications/outbreaks-under-monitoring-in-2026/outbreaks-under-monitoring-week-39-week-ending-27-september-2026
WHO, “Statement of the Forty-fifth Meeting of the Polio IHR Emergency Committee,” August 25, 2026. https://www.who.int/news/item/25-08-2026-statement-of-the-forty-fifth-meeting-of-the-polio-ihr-emergency-committee
WHO, “WHO statement on the first meeting of the International Health Regulations (2005) Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations,” February 1, 2016. https://www.who.int/news/item/01-02-2016-who-statement-on-the-first-meeting-of-the-international-health-regulations-(2005)-(ihr-2005)-emergency-committee-on-zika-virus-and-observed-increase-in-neurological-disorders-and-neonatal-malformations
Chulwoo Park, “Lessons learned from the World Health Organization’s late initial response to the 2014–2016 Ebola outbreak in West Africa,” Journal of Public Health in Africa, Vol. 13, No. 1, 2022. https://pmc.ncbi.nlm.nih.gov/articles/PMC9202458/
Mark Honigsbaum, “Between Securitisation and Neglect: Managing Ebola at the Borders of Global Health,” Medical History, Vol. 61, No. 2, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5426310/
Harvard-LSHTM Independent Panel on the Global Response to Ebola, “Will Ebola change the game? Ten essential reforms before the next pandemic,” The Lancet, Vol. 386, November 2015. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00946-0/fulltext · https://pmc.ncbi.nlm.nih.gov/articles/PMC7137174/
WHO, “Report of the Ebola Interim Assessment Panel,” July 2015. https://www.who.int/docs/default-source/documents/evaluation/report-ebola-interim-assessment-panel.pdf
WHO, “Statement to the 148th Executive Board by the Chair of the Review Committee on the Functioning of the International Health Regulations (2005) during the COVID-19 Response,” January 19, 2021. https://www.who.int/news/item/19-01-2021-statement-to-the-148th-executive-board-by-the-chair-of-the-review-committee-on-the-functioning-of-the-international-health-regulations-(2005)-during-the-covid-19-response
WHO, “Emergency grading.” https://www.who.int/emergencies/grading
WHO, “International Health Regulations Monitoring and Evaluation Framework.” https://www.who.int/emergencies/operations/international-health-regulations-monitoring-evaluation-framework
WHO, Contingency Fund for Emergencies: 2025 Annual Report, 2026. https://www.who.int/publications/i/item/9789240122987
“World Bank pandemic facility ‘an embarrassing mistake,’ says former chief economist,” Devex, 2019. https://www.devex.com/news/world-bank-pandemic-facility-an-embarrassing-mistake-says-former-chief-economist-94697
“World Bank abandons pandemic bond instrument after disastrous Covid-19 response,” Bretton Woods Project, October 2020. https://www.brettonwoodsproject.org/2020/10/world-bank-abandons-pandemic-bond-instrument-after-disastrous-covid-19-response/
World Bank, “Fact sheet: Pandemic Emergency Financing Facility.” https://www.worldbank.org/en/topic/pandemics/brief/fact-sheet-pandemic-emergency-financing-facility · https://www.worldbank.org/en/topic/pandemics/brief/pandemic-emergency-financing-facility
UK Government Actuary’s Department, “Pandemic bonds: what are they and how do they work?,” March 2021. https://actuaries.blog.gov.uk/2021/03/02/pandemic-bonds-what-are-they-and-how-do-they-work/
Colin McInnes, “WHO’s next? Changing authority in global health governance after Ebola,” International Affairs, Vol. 91, No. 6, 2015. https://academic.oup.com/ia/article/91/6/1299/2326948
WHO, “SARS: Chronology of a serial killer,” Update 95, July 4, 2003. https://www.who.int/emergencies/disease-outbreak-news/item/2003_07_04-en
Barbara Frossard Pagotto and Mark Eccleston-Turner, “The Politics of Public Health Emergencies of International Concern,” Global Studies Quarterly, Vol. 4, No. 4, 2024. https://doi.org/10.1093/isagsq/ksae083
Catherine Z. Worsnop, “International Border Restrictions During COVID-19 as Global Health Security Theatre,” British Journal of Political Science, Vol. 55, Cambridge University Press, 2025. https://www.cambridge.org/core/journals/british-journal-of-political-science/article/international-border-restrictions-during-covid19-as-global-health-security-theatre/959CADA7A8796FCA7634425D81E98750
Catherine Z. Worsnop, Karen A. Grépin, Kelley Lee and Summer Marion, “The Unintended Consequences of Information Provision: The World Health Organization and Border Restrictions during COVID-19,” International Studies Perspectives, Vol. 24, No. 1, 2023. https://doi.org/10.1093/isp/ekac010
WHO, “Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern,” July 17, 2019. https://www.who.int/news/item/17-07-2019-ebola-outbreak-in-the-democratic-republic-of-the-congo-declared-a-public-health-emergency-of-international-concern
WHO, “Statement on the meeting of the International Health Regulations (2005) Emergency Committee for Ebola virus disease in the Democratic Republic of the Congo,” June 14, 2019. https://www.who.int/news/item/14-06-2019-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-for-ebola-virus-disease-in-the-democratic-republic-of-the-congo
Bárbara Frossard Pagotto, “When should a public health emergency of international concern be declared? The case of the 2018–2020 Ebola outbreak in the Democratic Republic of the Congo,” Health Policy and Planning, Vol. 41, No. 8, 2026. https://doi.org/10.1093/heapol/czag094
WHO, “Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa,” August 8, 2014. https://www.who.int/news/item/08-08-2014-statement-on-the-1st-meeting-of-the-ihr-emergency-committee-on-the-2014-ebola-outbreak-in-west-africa
WHO, “Ebola virus disease update – West Africa,” Disease Outbreak News, August 8, 2014. https://www.who.int/emergencies/disease-outbreak-news/item/2014_08_08_ebola-en
WHO, “Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme: report to the Seventy-third World Health Assembly,” A73/10, 2020. https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_10-en.pdf
World Bank, “The Economic Impact of the 2014 Ebola Epidemic: Short and Medium Term Estimates for West Africa,” 2014. https://www.worldbank.org/en/region/afr/publication/the-economic-impact-of-the-2014-ebola-epidemic-short-and-medium-term-estimates-for-west-africa
World Bank, “Update on the Economic Impact of the 2014–2015 Ebola Epidemic on Liberia, Sierra Leone, and Guinea,” 2015. https://openknowledge.worldbank.org/entities/publication/36e651db-3aca-5cdb-9865-0df4e314aaec
